Latest News and Press Releases
Want to stay updated on the latest news?
-
SAN FRANCISCO, July 20, 2023 (GLOBE NEWSWIRE) -- Tecton, the leading machine learning (ML) feature platform company, today announced the results of a comprehensive ML survey of 1700 respondents. The...
-
LONDON, July 20, 2023 (GLOBE NEWSWIRE) -- According to The Business Research Company’s IT consulting market forecast, the global IT consulting market size is expected to grow from $97.48 billion in...
-
WESTPORT, Conn., July 20, 2023 (GLOBE NEWSWIRE) -- HMG Strategy, the World’s #1 platform for enabling technology executives to reimagine the enterprise and reshape the business world, is excited to...
-
MOUNTAIN VIEW, Calif., July 19, 2023 (GLOBE NEWSWIRE) -- Lily AI ("Lily" or the "Company"), a retail AI platform specializing in computer vision, natural language processing and machine learning for...
-
BROOKLINE, Mass., July 19, 2023 (GLOBE NEWSWIRE) -- Ukrainian-founded Preply reached a milestone in the company’s funding history today, raising an additional $70 million in equity and debt capital...
-
NEW YORK and KUALA LUMPUR, Malaysia, July 19, 2023 (GLOBE NEWSWIRE) -- Treasure Global Inc (NASDAQ: TGL) (“TGL”, “Treasure Global,” or the “Company”), an innovative technology solutions provider,...
-
KUALA LUMPUR, Malaysia, July 19, 2023 (GLOBE NEWSWIRE) -- VCI Global Limited (NASDAQ: VCIG) (“VCI Global”, or the “Company”) announced that the Company will be collaborating with Treasure Global Inc...
-
BOSTON, July 19, 2023 (GLOBE NEWSWIRE) -- Jnana Therapeutics, a clinical-stage biotechnology company leveraging its next-generation chemoproteomics platform to discover medicines for...
-
THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO AUSTRALIA, CANADA, ITALY, DENMARK, JAPAN, THE UNITED STATES, OR TO ANY NATIONAL OF SUCH JURISDICTIONS 18...
-
FDA approves Beyfortus™ (nirsevimab-alip) to protect infants against RSV disease Beyfortus™ is the first monoclonal antibody approved to protect all infants through their first RSV seasonAcross all...